Beese Fulmer Investment Management’s Boston Scientific BSX Stock Holding History

Beese Fulmer Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287K	Sell	6,729 -213,012	-97%	-$11.6M	0.02%	311
2026 Q1	$13.8M	Sell	219,741 -2,285	-1%	-$183K	0.88%	37
2025 Q4	$21.2M	Buy	222,026 +217,531	+4,839%	+$21.3M	1.38%	21
2025 Q3	$439K	Buy	+4,495	New	+$466K	0.03%	203

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Beese Fulmer Investment Management's BSX Position: Q2 2026 in Review

Beese Fulmer Investment Management reduced its Boston Scientific (BSX) stake by 97% in Q2 2026, selling an estimated $11.6M and leaving 6,729 shares worth $287K. The position accounts for 0.02% of the portfolio, ranked #311.

Beese Fulmer Investment Management first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $21.2M in Q4 2025. 471 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Beese Fulmer Investment Management held 6,729 shares of Boston Scientific worth $287K as of Q2 2026.
Beese Fulmer Investment Management sold 213,012 Boston Scientific shares in Q2 2026, an estimated $11.6M.
Boston Scientific made up 0.02% of Beese Fulmer Investment Management's portfolio in Q2 2026, its #311 holding.
Beese Fulmer Investment Management first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
Beese Fulmer Investment Management's Boston Scientific position peaked at $21.2M in Q4 2025.
471 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.